Loading...

PODCAST

The BioHub - by Avetix

Max Brennan - Biotech HeadHunter

Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that"s shaping the future of biotechnology. Get ready for an immersive

science life sciences

All Episodes

00:36:15

Episode 219 - Prakash Raman - CEO of InduPro...

The BioHub - by Avetix ·

2026/09/02

We were delighted to be joined by Prakash Raman, Ph.D., CEO of InduPro Therapeutics.Prakash brings more than two decades of experience across the biopharmaceutical industry, spanning business development, licensing, portfolio strategy, venture creation and executive leadership. Before joining InduPro, he was President and CEO of Ribon Therapeutics, following a period as Senior Partner and Chief Business Development Officer at Flagship Pioneering. Prior to that, he spent almost 14 years at Novartis,

en

00:21:56

Episode 220 - Kristen Stants - Chief People Officer...

The BioHub - by Avetix ·

2026/09/02

In this episode of The BioHub by Avetix, I’m joined by Kristen Stants, Chief People Officer at Parabilis Medicines.Recorded shortly after Parabilis completed its record-breaking IPO, Kristen shares what that milestone means for the company and how the people strategy changes when a biotech suddenly enters a new phase of rapid growth.We also discuss how to protect culture while scaling, the qualities that help people thrive in biotech, what strong leadership looks like in a volatile industry, and

en

00:23:35

Episode 218 - JD Finley & Mitch Jones - Palisade Bio

The BioHub - by Avetix ·

2026/08/31

On this episode we're joined by Palisade Bio's CEO & CMO, JD Finley & Mitch Jones.In Q2 2026, Palisade released promising ph1 data for their lead asset - PALI2108 - a PDE4 inhibitor. With recent IND clearance for their ph2 ASCENTRA-UC study, we discuss that data, and what real success looks like clinically & commercially for the business & asset moving forward, in an increasingly busy IBD market. We hope you enjoy the episode.

en

00:27:16

Episode 217 - Kristen Wong - Partner Altitude VC

The BioHub - by Avetix ·

2026/08/27

In this episode of The BioHub by Avetix, I’m joined by Kristen Wong of Altitude Life Science Ventures.Kristen shares her journey into venture capital and how she thinks about identifying the people and companies worth backing at the earliest stages. We discuss why the investments you pass on can be just as valuable as the ones you make, the importance of founder emotional intelligence, and what the SVB crisis taught her about supporting companies through uncertainty.We also explore where AI is

en

00:20:14

Episode 216 - Tom Ciulla - CEO Ikarovec

The BioHub - by Avetix ·

2026/08/17

In this episode we meet Tom Ciulla, CEO of Ikarovec, one of the most exciting gene therapy biotechs in The UK and the ophthalmology scene more broadly. Ikarovec isn't Tom's first rodeo - playing a role in the rise of Iveric, Spark, Viridian, and Nanoscope - but as a first-time CEO, tune in to hear what excited him the most about Ikarovec's bicistronic platform, their plans for clinical trials in GA & RP, and the latest on their Series A.

en

00:37:12

Episode 215 - Nykode - Michael & Agnete - CEO & CSO

The BioHub - by Avetix ·

2026/08/13

In this episode of The BioHub by Avetix, I’m joined by Michael Engsig, CEO of Nykode Therapeutics, and Agnete Fredriksen, Co-Founder and Chief Scientific Officer.Michael and Agnete share the story behind Nykode, how the company’s technology has evolved, and what they’ve learned from building a biotech around a novel approach to immunotherapy.We also discuss the balance between scientific ambition and commercial execution, the challenges of developing new cancer treatments, how the CEO and CSO roles

en

00:33:17

Episode 214 - David Crean - CBO at MediciNova

The BioHub - by Avetix ·

2026/08/10

In this episode of The BioHub Podcast by Avetix, Ben sits down with Dr. David Crean, Chief Business Officer at MediciNova, to explore a career spanning biotechnology, investment, M&A and strategic partnering.The conversation explores David’s journey into biotech, how he evaluates opportunities and partnerships, and the decisions that shape the development of emerging therapeutics. We also discuss MediciNova’s work in neurological disease, including the development of MN-166 (ibudilast), and the

en

00:37:44

Episode 215 - Kathleen Gallagher - CEO at Atrium...

The BioHub - by Avetix ·

2026/08/10

We were delighted to be joined by Kathleen Gallagher, CEO of Atrium Therapeutics.Kathleen has built a fascinating career across the biotech industry, with experience spanning corporate communications, investor relations, clinical development and executive leadership. Before founding Atrium, she spent time at companies including Merrimack Pharmaceuticals and Akcea Therapeutics, before joining Avidity Biosciences, where she ultimately became Chief Program Officer.At Avidity, Kathleen was closely

en

00:29:12

Episode 213 - Fred Aslan - CEO Artiva Bio

The BioHub - by Avetix ·

2026/08/07

In this episode of The BioHub by Avetix, I’m joined by Fred Aslan, President and CEO of Artiva Biotherapeutics.Fred shares his journey across venture capital, business development and biotech leadership, including his time at Venrock and Vividion, and how those experiences shaped the way he now leads Artiva.We discuss what it takes to build and scale a biotech, how investor experience changes the way you make decisions as a CEO, the opportunity for off-the-shelf cell therapies, and where Fred sees

en

00:20:44

Episode 212 - Luis Pena - Founder & CEO Evommune

The BioHub - by Avetix ·

2026/08/06

In this episode of The BioHub by Avetix, I’m joined by Luis Peña, Co-Founder, President and CEO of Evommune.Luis shares his journey from scientist to biotech founder, including the story behind building Dermira and the lessons he took from its acquisition by Eli Lilly. We discuss why he decided to start again with Evommune and the company’s ambition to develop new treatments for chronic inflammatory diseases.We also explore what it takes to build and finance a biotech, the transition into the CEO

en

00:16:37

Episode 211 - Meredith Kaya - Corsera Health

The BioHub - by Avetix ·

2026/08/04

In Q1 of this year, I sat down with Meredith, CFO at Corsera Health, to discuss the future of cardiovascular health and why prediction and prevention are becoming increasingly important in improving outcomes long before a CVD diagnosis.We explored what it takes to build a company at the intersection of science, data and healthcare, how finance and strategy support innovation.A really insightful conversation with Meredith on the opportunities and challenges of building a company focused on tackling

en

00:23:47

Episode 210 - Dana Watt - Partner at Breakout Ventures

The BioHub - by Avetix ·

2026/08/04

In this episode of the BioHub by Avetix, we’re joined by Dana Watt, Partner at Breakout Ventures, to explore how she evaluates ambitious science-led businesses at the earliest stages.Dana discusses her journey from neuroscience and company building into venture capital, what separates an exciting technology from an investable company, and the signals she looks for in scientific founders. We also explore how Breakout supports companies beyond capital, the changing investment environment for biotech

en

00:22:42

Episode 209 - Pam Stetkiewicz Lyora Therapeutics

The BioHub - by Avetix ·

2026/08/03

Todays episode we welcomed Pam Stetkiewicz from Lyora Therapeutics on the BioHub Podcast.

en

00:25:09

Episode 208 - Handol Kim - CEO Variational AI

The BioHub - by Avetix ·

2026/08/03

In this episode of The BioHub by Avetix, I’m joined by Handol Kim, Co-Founder and CEO of Variational AI.Recorded at BIO 2026, Handol shares his unconventional journey from more than two decades in technology into biotech, and why he chose to apply generative AI to one of science’s most difficult challenges: discovering new medicines. Variational AI’s Enki platform is purpose-built to generate novel, synthesizable small molecules designed around a specific target product profile. We discuss the

en

00:31:18

Episode 207 - Ola Wlodek - CEO of Constructive Bio

The BioHub - by Avetix ·

2026/07/30

We were delighted to be joined by Ola Włodek, a biotech executive and the CEO of Constructive Bio, a company at the forefront of synthetic biology and the development of new ways to engineer biology and create novel molecules.Ola brings a wealth of experience across the life sciences industry, with a background spanning strategy, operations, and business leadership. At Constructive Bio, she is part of the team working to translate cutting-edge synthetic biology into a platform capable of creating

en

00:26:09

Episode 206 - Valerie Vanhooren - CEO & Co-Founder...

The BioHub - by Avetix ·

2026/07/23

In this episode of The BioHub by Avetix, I'm joined by Valerie Vanhooren, CEO and Co-Founder of Ona Therapeutics.Recorded shortly after Ona Therapeutics announced its $85 million Series B, Valerie shares the journey behind building the company, the challenges of fundraising in today's biotech market, and the opportunity to develop next-generation precision oncology therapies that improve outcomes for patients with cancer.We also discuss the evolution of antibody-drug conjugates (ADCs), what

en

00:22:48

Episode 205 - Paul Bresge - CEO of Ray Therapeutics

The BioHub - by Avetix ·

2026/07/22

Paul didn't stumble into biotech, he was pulled in by a diagnosis. When a doctor told his daughter to prepare for a life without her sight due to retinitis pigmentosa, he went all in on finding the best science out there to give patients like her new hope. Today he leads Ray Therapeutics, who're developing optogenetic gene therapies designed to restore vision, not just slow its loss, for patients who are already out of other options. We talk about the science, the personal mission, and what's coming

en

00:29:00

Episode 204 - Samir Ounzain - Co-founder & CEO Haya...

The BioHub - by Avetix ·

2026/07/20

In this episode of The BioHub by Avetix, I'm joined by Samir Ounzain, CEO and Co-Founder of HAYA Therapeutics.Samir shares the journey from pioneering research into the so-called "dark genome" to building one of biotech's most exciting RNA therapeutics companies. We discuss why long non-coding RNAs could unlock an entirely new class of precision medicines, the challenge of turning groundbreaking science into a business, and how HAYA is approaching diseases with significant unmet need.We also explore

en

00:26:14

Episode 203 - Tim Noyes - CEO of Newleos Therapeutics

The BioHub - by Avetix ·

2026/07/20

In this episode of The BioHub Podcast, Ben is joined by Tim Noyes, President and CEO of Newleos Therapeutics.Tim reflects on more than 35 years across the life sciences industry, from beginning his career at Merck to building and leading emerging biotechnology companies. He shares why he has consistently been drawn to smaller organisations, where leadership teams can remain close to the science, the patients and the people driving the company forward.The conversation explores Newleos’ mission to

en

00:33:33

Episode 202 - Ben Swanson - CEO of Skeletalis

The BioHub - by Avetix ·

2026/07/16

Today we're joined by Ben Swanson, Founder and CEO of Skeletalis, a biotechnology company developing a new generation of precision medicines for bone disease.Ben's path into biotech is anything but conventional. Trained as both a dentist and a scientist, he founded Skeletalis to tackle one of the biggest unmet challenges in musculoskeletal health: how to deliver treatments directly to the parts of the skeleton that need them most, while minimizing effects on the rest of the body.At

en

267 results

Similar Podcasts

The Deep Dive Lab: Unraveling Materials Science

Son Hoang

New Books in Political Science

New Books Network

Station 151

Pale Matter | Realm

Beyond the Divide

Koala Moon

StarTalk with Neil deGrasse Tyson

Neil deGrasse Tyson